Vimarsana
Biggest News Aggregation in the World

Page 30 - Entrypoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entrypoint Capital Today - Breaking & Trending Today

Citigroup Increases Dell Technologies (NYSE:DELL) Price Target to $170.00 - Vimarsana News

Citigroup Increases Dell Technologies (NYSE:DELL) Price Target to $170.00

Dell Technologies (NYSE:DELL – Free Report) had its price target raised by Citigroup from $125.00 to $170.00 in a research report released on Tuesday, Marketbeat.com reports. They currently have a buy rating on the technology company’s stock. A number of other analysts also recently weighed in on the company. Loop Capital began coverage on Dell […]

Source: wkrb13.com
Raymond James Lowers Chewy (NYSE:CHWY) Price Target to $19.00 - Vimarsana News

Raymond James Lowers Chewy (NYSE:CHWY) Price Target to $19.00

Chewy (NYSE:CHWY – Get Free Report) had its price objective reduced by research analysts at Raymond James from $20.00 to $19.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Raymond James’ target price would suggest a potential upside of 14.46% from the company’s […]

Omnicell, Inc. (NASDAQ:OMCL) Given Average Rating of "Hold" by Brokerages - Vimarsana News

Omnicell, Inc. (NASDAQ:OMCL) Given Average Rating of "Hold" by Brokerages

Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) has been assigned an average rating of “Hold” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The […]

Larimar Therapeutics (NASDAQ:LRMR) Receives Market Outperform Rating from JMP Securities - Vimarsana News

Larimar Therapeutics (NASDAQ:LRMR) Receives Market Outperform Rating from JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Larimar Therapeutics (NASDAQ:LRMR – Free Report) in a report released on Tuesday, Benzinga reports. They currently have a $25.00 price objective on the stock. Several other brokerages also recently commented on LRMR. Citigroup increased their price objective on Larimar Therapeutics from $4.50 to $10.00 and […]

Source: wkrb13.com
Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB) Downgraded by StockNews.com - Vimarsana News

Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB) Downgraded by StockNews.com

StockNews.com downgraded shares of Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB – Free Report) from a hold rating to a sell rating in a research report released on Tuesday morning. Several other brokerages have also weighed in on HOMB. Royal Bank of Canada reissued a sector perform rating and issued a $26.00 price objective on shares […]